$CREX
CREATIVE REALITIES, INC. Stock $crex

$crex Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000143774923014573 Filed on May 15, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$9.196M	$9.944M	$10.76M
YoY Change	-15.81%	-7.56%	115.14%
Cost Of Revenue	$4.898M	$4.855M	$6.865M
YoY Change	-21.77%	-29.28%	147.83%
Gross Profit	$4.298M	$5.089M	$3.892M
YoY Change	-7.81%	30.76%	74.53%
Gross Profit Margin	46.74%	51.18%	36.18%
Selling, General & Admin	$3.824M	$4.034M	$3.567M
YoY Change	3.1%	13.09%	84.82%
% of Gross Profit	88.97%	79.27%	91.65%
Research & Development	$377.0K	$366.0K	$241.0K
YoY Change	-9.81%	51.87%	41.76%
% of Gross Profit	8.77%	7.19%	6.19%
Depreciation & Amortization	$797.0K	$779.0K	$707.0K
YoY Change	70.3%	10.18%	107.94%
% of Gross Profit	18.54%	15.31%	18.17%
Operating Expenses	$4.998M	$5.179M	$4.515M
YoY Change	7.9%	14.71%	84.29%
Operating Profit	-$700.0K	-$90.00K	-$623.0K
YoY Change	-2433.33%	-85.55%	183.18%
Interest Expense	$787.0K	$803.0K	$5.020M
YoY Change	4.93%	-84.0%	-2108.0%
% of Operating Profit
Other Income/Expense, Net	-$680.0K	-$867.0K	$6.000K
YoY Change	-152.92%	-14550.0%
Pretax Income	-$1.380M	-$957.0K	$2.505M
YoY Change	-204.94%	-138.2%	97.24%
Income Tax	$45.00K	$43.00K	$3.000K
% Of Pretax Income			0.12%
Net Earnings	-$1.425M	-$1.000M	$2.502M
YoY Change	-212.92%	-139.97%	97.01%
Net Earnings / Revenue	-15.5%	-10.06%	23.26%
Basic Earnings Per Share	-$0.19	-$0.14	$0.51
Diluted Earnings Per Share	-$0.19	-$0.14	$171.2K
COMMON SHARES
Basic Shares Outstanding	7.409M	7.394M	4.873M
Diluted Shares Outstanding	7.406M	7.351M	4.873M

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.264M	$3.905M	$5.988M
YoY Change	14.93%	-34.79%	69.15%
Cash & Equivalents	$3.264M	$3.905M	$5.988M
Short-Term Investments
Other Short-Term Assets	$784.0K	$804.0K	$2.325M
YoY Change	-74.8%	-65.42%	252.27%
Inventory	$1.148M	$1.479M	$2.024M
Prepaid Expenses
Receivables	$6.496M	$6.849M	$8.806M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$11.69M	$13.04M	$19.14M
YoY Change	-32.0%	-31.9%	88.6%
LONG-TERM ASSETS
Property, Plant & Equipment	$453.0K	$245.0K	$1.227M
YoY Change	223.57%	-80.03%	-41.57%
Goodwill	$26.45M	$26.45M
YoY Change	1.38%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$44.00K	$44.00K	$52.00K
YoY Change	158.82%	-15.38%	420.0%
Total Long-Term Assets	$52.24M	$52.07M	$43.74M
YoY Change	1.79%	19.04%	229.34%
TOTAL ASSETS
Total Short-Term Assets	$11.69M	$13.04M	$19.14M
Total Long-Term Assets	$52.24M	$52.07M	$43.74M
Total Assets	$63.93M	$65.10M	$62.88M
YoY Change	-6.69%	3.54%	168.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.892M	$3.087M	$4.881M
YoY Change	-42.7%	-36.75%	214.9%
Accrued Expenses	$3.217M	$3.726M	$3.019M
YoY Change	20.4%	23.42%	20.76%
Deferred Revenue	$2.827M	$3.605M
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$4.197M	$4.944M	$2.396M
YoY Change	100.91%	106.34%	46.1%
Total Short-Term Liabilities	$17.76M	$16.86M	$16.86M
YoY Change	7.37%	0.02%	109.9%
LONG-TERM LIABILITIES
Long-Term Debt	$11.59M	$12.42M	$13.03M
YoY Change	-13.47%	-4.64%	101.06%
Other Long-Term Liabilities	$136.0K	$80.00K	$13.94M
YoY Change	-98.88%	-99.43%	2077.34%
Total Long-Term Liabilities	$11.72M	$12.50M	$26.96M
YoY Change	-54.1%	-53.63%	278.71%
TOTAL LIABILITIES
Total Short-Term Liabilities	$17.76M	$16.86M	$16.86M
Total Long-Term Liabilities	$11.72M	$12.50M	$26.96M
Total Liabilities	$40.08M	$40.02M	$43.82M
YoY Change	-4.76%	-8.67%	189.23%
SHAREHOLDERS EQUITY
Retained Earnings	-$52.83M	-$51.41M
YoY Change	8.89%
Common Stock	$74.00K	$74.00K
YoY Change	-65.9%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$23.86M	$25.08M	$19.06M
YoY Change
Total Liabilities & Shareholders Equity	$63.93M	$65.10M	$62.88M
YoY Change	-6.69%	3.54%	168.37%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$1.425M	-$1.000M	$2.502M
YoY Change	-212.92%	-139.97%	97.01%
Depreciation, Depletion And Amortization	$797.0K	$779.0K	$707.0K
YoY Change	70.3%	10.18%	107.94%
Cash From Operating Activities	$2.476M	$3.868M	$1.201M
YoY Change	-295.89%	222.06%	-6105.0%
INVESTING ACTIVITIES
Capital Expenditures	$1.169M	$31.00K	-$785.0K
YoY Change	-174.22%	-103.95%	554.17%
Acquisitions		$0.00	$17.18M
YoY Change		-100.0%
Other Investing Activities	$0.00	$0.00	-$17.18M
YoY Change	-100.0%	-100.0%
Cash From Investing Activities	-$1.169M	-$1.034M	-$17.97M
YoY Change	-25.87%	-94.25%	14874.17%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.948M	-$562.0K	19.87M
YoY Change	534.53%	-102.83%	974.22%
NET CHANGE
Cash From Operating Activities	2.476M	$3.868M	1.201M
Cash From Investing Activities	-1.169M	-$1.034M	-17.97M
Cash From Financing Activities	-1.948M	-$562.0K	19.87M
Net Change In Cash	-641.0K	$2.272M	3.105M
YoY Change	-79.64%	-26.83%	81.58%
FREE CASH FLOW
Cash From Operating Activities	$2.476M	$3.868M	$1.201M
Capital Expenditures	$1.169M	$31.00K	-$785.0K
Free Cash Flow	$1.307M	$3.837M	$1.986M
YoY Change	320.26%	93.2%	1886.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	66666000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	66666000
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7394000
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7394000
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7266000
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7266000
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	1777000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-33169
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MN
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	41-1967918
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	13100 Magisterial Drive, Suite 100
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Louisville
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	KY
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	40223
CY2023Q1	dei	City Area Code CityAreaCode	502
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	791-8800
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	7409027
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3905000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1633000	usd
CY2023Q1	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	6849000	usd
CY2022Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	8263000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	1479000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	2267000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	804000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1819000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	13037000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	13982000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	245000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	201000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1504000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1584000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	23819000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	23752000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	26453000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	26453000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	44000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	43000	usd
CY2023Q1	us-gaap	Assets Assets	65102000	usd
CY2022Q4	us-gaap	Assets Assets	66015000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	3087000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3757000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3726000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3828000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3605000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1223000	usd
CY2023Q1	crex	Customer Deposit Current CustomerDepositCurrent	785000	usd
CY2022Q4	crex	Customer Deposit Current CustomerDepositCurrent	2478000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	712000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	711000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	16859000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	16496000	usd
CY2023Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	0	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	208000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	792000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	873000	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	9865000	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	9789000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	80000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	205000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	40020000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	40436000	usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	74000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	72000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	76417000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	75916000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-51409000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-50409000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	25082000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	25579000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	65102000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	66015000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	9944000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	10757000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4855000	usd
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	6865000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	5089000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	3892000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1136000	usd
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	707000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	366000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	241000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2898000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2860000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	779000	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	707000	usd
CY2023Q1	crex	Deal And Transaction Costs DealAndTransactionCosts	0	usd
CY2022Q1	crex	Deal And Transaction Costs DealAndTransactionCosts	391000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	5179000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	4906000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-90000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1014000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	803000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	449000	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	76000	usd
CY2022Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-0	usd
CY2023Q1	crex	Gain Loss On Settlement Of Debt GainLossOnSettlementOfDebt	0	usd
CY2022Q1	crex	Gain Loss On Settlement Of Debt GainLossOnSettlementOfDebt	-295000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	12000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	6000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-867000	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3519000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-957000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2505000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	43000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1000000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	2502000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.51
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.51
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7351000
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4873000
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7351000
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4873000
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1000000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	2502000	usd
CY2023Q1	crex	Depreciation Depletion And Amortization Excluding Amortization Of Debt Discount Premium DepreciationDepletionAndAmortizationExcludingAmortizationOfDebtDiscountPremium	779000	usd
CY2022Q1	crex	Depreciation Depletion And Amortization Excluding Amortization Of Debt Discount Premium DepreciationDepletionAndAmortizationExcludingAmortizationOfDebtDiscountPremium	707000	usd
CY2023Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	356000	usd
CY2022Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	181000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	298000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	551000	usd
CY2023Q1	crex	Employee Retention And Other Government Credits EmployeeRetentionAndOtherGovernmentCredits	0	usd
CY2022Q1	crex	Employee Retention And Other Government Credits EmployeeRetentionAndOtherGovernmentCredits	16000	usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-0	usd
CY2022Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-295000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	237000	usd
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	116000	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	76000	usd
CY2022Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	24000	usd
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1177000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3724000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-788000	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-52000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1015000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-777000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-486000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2292000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-45000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	35000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	2382000	usd
CY2022Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1901000	usd
CY2023Q1	crex	Increase Decrease In Customer Deposit IncreaseDecreaseInCustomerDeposit	-1693000	usd
CY2022Q1	crex	Increase Decrease In Customer Deposit IncreaseDecreaseInCustomerDeposit	-213000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	40000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	30000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3868000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1201000	usd
CY2023Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-0	usd
CY2022Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	17184000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	31000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	10000	usd
CY2023Q1	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	1003000	usd
CY2022Q1	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	775000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1034000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-17969000	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2000	usd
CY2022Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	-0	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	0	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	1814000	usd
CY2023Q1	crex	Proceeds From Warrant Issuance And Exercises ProceedsFromWarrantIssuanceAndExercises	0	usd
CY2022Q1	crex	Proceeds From Warrant Issuance And Exercises ProceedsFromWarrantIssuanceAndExercises	8295000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	9868000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-562000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	19873000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2272000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	3105000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1633000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2883000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3905000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5988000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	25579000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	139000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1000000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	25082000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	8729000	usd
CY2022Q1	crex	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	2278000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	5000000	usd
CY2022Q1	crex	Adjustments To Additional Paid In Capital Warrant Repricing AdjustmentsToAdditionalPaidInCapitalWarrantRepricing	0	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	2502000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	19060000	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	66666666
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-51409000	usd
CY2023Q1	crex	Working Capital WorkingCapital	-3822000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3905000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-90000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3868000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	984000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	237000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	4000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1217000	usd
CY2023Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	741000	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	1671000	usd
CY2023Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	738000	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	596000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	1479000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	2267000	usd
CY2023Q1	us-gaap	Inventory Write Down InventoryWriteDown	1777000	usd
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7339582
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6910962
CY2022	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	1731499
CY2023Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"/> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i><em style="font: inherit;">10.</em> Use of Estimates</i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Our significant estimates include: contingent purchase consideration valuation, allowance for credit losses, valuation allowances related to deferred taxes, the fair value of acquired assets and liabilities, the fair value of liabilities reliant upon the appraised fair value of the Company, valuation of stock-based compensation awards and other assumptions and estimates used to evaluate the recoverability of long-lived assets, goodwill and other intangible assets and the related amortization methods and periods. Actual results could differ from those estimates.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	9944000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	10757000	usd
CY2021Q4	crex	Business Combination Contingent Consideration Billable Devices Online Maximum Share Price BusinessCombinationContingentConsiderationBillableDevicesOnlineMaximumSharePrice	21.60
CY2022Q4	crex	Business Combination Contingent Consideration Billable Devices Online Maximum Share Price BusinessCombinationContingentConsiderationBillableDevicesOnlineMaximumSharePrice	19.20
CY2022Q4	crex	Business Combination Contingent Consideration Billable Devices Online Reduction In Share Price BusinessCombinationContingentConsiderationBillableDevicesOnlineReductionInSharePrice	2.40
CY2022Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	3069000	usd
CY2023Q1	crex	Capitalized Software In Accounts Payable CapitalizedSoftwareInAccountsPayable	369000	usd
CY2022Q1	crex	Capitalized Software In Accounts Payable CapitalizedSoftwareInAccountsPayable	611000	usd
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	10000	usd
CY2022Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	40000	usd
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	287000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	321000	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	188000	usd
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	75000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2000	usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	35972000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	12153000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	35151000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	11399000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	12153000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	11399000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	23819000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	23752000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	754000	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	680000	usd
CY2023Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	20081000	usd
CY2023Q1	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	1731499
CY2023Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	2713000	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	17368000	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	4944000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	17572000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	4499000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	12424000	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	20641000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	13073000	usd
CY2023Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	356000	usd
CY2022Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	162000	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	43000	usd
CY2023Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	52000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	28000	usd
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y8M12D
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	30000	usd
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	45000	usd

Files In Submission

Name	View Source	Status
crex-20230331_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
0001437749-23-014573-index-headers.html	Edgar Link	pending
0001437749-23-014573-index.html	Edgar Link	pending
0001437749-23-014573.txt	Edgar Link	pending
0001437749-23-014573-xbrl.zip	Edgar Link	pending
crex-20230331.xsd	Edgar Link	pending
crex20230331_10q.htm	Edgar Link	pending
crexlogonew.jpg	Edgar Link	pending
ex_498027.htm	Edgar Link	pending
ex_498028.htm	Edgar Link	pending
ex_498029.htm	Edgar Link	pending
crex-20230331_lab.xml	Edgar Link	unprocessable
crex-20230331_pre.xml	Edgar Link	unprocessable
crex20230331_10q_htm.xml	Edgar Link	completed
ex_498030.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
crex-20230331_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CREX
CREATIVE REALITIES, INC. Stock $crex

2023 Q2 Form 10-Q Financial Statement

#000143774923014573 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CREX CREATIVE REALITIES, INC. Stock $crex

2023 Q2 Form 10-Q Financial Statement

#000143774923014573 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CREX
CREATIVE REALITIES, INC. Stock $crex